Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Journal of Translational Medicine
Published in: Journal of Translational Medicine 1/2010

Open Access 01-11-2010 | Poster presentation

Interstitial lung disease in patients with scleroderma - Treatment with rituximab

Authors: A Muñoz, R Martínez, S Rodríguez, M L Velloso, J L Marenco

Published in: Journal of Translational Medicine | Special Issue 1/2010

Login to get access

Excerpt

Interstitial Lung Disease (ILD) is a severe complication of systemic sclerosis, more common among patients with diffuse scleroderma. Cyclophosphamide (CYC) is the treatment normally used in those patients, with irregular response. We have successfully treated 3 patients refractory to CYC with Rituximab (RTX). …
Metadata
Title
Interstitial lung disease in patients with scleroderma - Treatment with rituximab
Authors
A Muñoz
R Martínez
S Rodríguez
M L Velloso
J L Marenco
Publication date
01-11-2010
Publisher
BioMed Central
Published in
Journal of Translational Medicine / Issue Special Issue 1/2010
Electronic ISSN: 1479-5876
DOI
https://doi.org/10.1186/1479-5876-8-S1-P45

Other articles of this Special Issue 1/2010

Journal of Translational Medicine 1/2010 Go to the issue

Invited lecture presentation

Biomarkers inform clinical trials and pathogenesis in systemic sclerosis

Poster presentation

Expression of IL-1 family members upon stimulation with IL-17 differs in keratinocytes derived from psoriasis patients and healthy donors

Poster presentation

Lack of adalimumab's complement dependent cytotoxicity on human cells expressing complement regulatory proteins

Oral presentation

Cytosolic phospholipase A2α gene silencing in monocytes alters development of Th1 responses and reduces autoimmune arthritis

Poster presentation

Preferential expression of NF-κB-inducing kinase (NIK) in blood vessels of rheumatoid arthritis synovial tissue containing ectopic lymphoid neogenesis

Oral presentation

Single-cell analysis techniques reveal a striking heterogeneity of human CD4+ T cell subsets

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits